• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一类新型的变构作用配体增强了神经元烟碱型乙酰胆碱受体的激动剂反应。

Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands.

作者信息

Schrattenholz A, Pereira E F, Roth U, Weber K H, Albuquerque E X, Maelicke A

机构信息

Laboratory of Molecular Neurobiology, Johannes-Gutenberg University Medical School, Mainz, Germany.

出版信息

Mol Pharmacol. 1996 Jan;49(1):1-6.

PMID:8569694
Abstract

Similar to the gamma-aminobutyric acidA receptor and the N-methyl-D-aspartate subtype of glutamate receptor, neuronal nicotinic acetylcholine receptors are subject to positive modulatory control by allosterically acting ligands. Exogenous ligands such as galanthamine and the neurotransmitter 5-hydroxytryptamine, when applied in submicromolar concentrations with nicotinic agonists, significantly increase the frequency of opening of nicotinic receptor channels and potentiate agonist-activated currents. Because these effects have been shown to be blocked by the monoclonal antibody FK1, they are mediated by binding sites that are located on alpha subunits of nicotinic receptors and distinct from those for acetylcholine and acetylcholine-competitive ligands. At higher concentrations, the potentiating effect of these ligands decreases and is eventually overcome by an inhibition of the agonist-induced response. The sensitizing actions of galanthamine, 5-hydroxytryptamine, and related compounds, at submicromolar concentrations, may reflect the existence of cross-talk between adjacent neuroreceptors and synapses in the central nervous system and thus suggests the formation of transiently active chemical networks in the vertebrate brain.

摘要

与γ-氨基丁酸A受体和谷氨酸受体的N-甲基-D-天冬氨酸亚型类似,神经元烟碱型乙酰胆碱受体受到变构作用配体的正向调节控制。外源性配体如加兰他敏和神经递质5-羟色胺,当与烟碱激动剂以亚微摩尔浓度共同应用时,可显著增加烟碱受体通道的开放频率并增强激动剂激活的电流。由于这些效应已被单克隆抗体FK1阻断,它们是由位于烟碱受体α亚基上且与乙酰胆碱和乙酰胆碱竞争性配体的结合位点不同的结合位点介导的。在较高浓度下,这些配体的增强作用会降低,并最终被激动剂诱导反应的抑制所克服。加兰他敏、5-羟色胺及相关化合物在亚微摩尔浓度下的致敏作用,可能反映了中枢神经系统中相邻神经受体和突触之间存在串扰,因此提示脊椎动物大脑中形成了瞬时活跃的化学网络。

相似文献

1
Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands.一类新型的变构作用配体增强了神经元烟碱型乙酰胆碱受体的激动剂反应。
Mol Pharmacol. 1996 Jan;49(1):1-6.
2
Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons.培养海马神经元烟碱型乙酰胆碱受体上新激动剂位点的鉴定及功能表征
J Pharmacol Exp Ther. 1993 Jun;265(3):1474-91.
3
Physostigmine and galanthamine: probes for a novel binding site on the alpha 4 beta 2 subtype of neuronal nicotinic acetylcholine receptors stably expressed in fibroblast cells.毒扁豆碱和加兰他敏:用于在成纤维细胞中稳定表达的神经元烟碱型乙酰胆碱受体α4β2亚型上新型结合位点的探针。
J Pharmacol Exp Ther. 1994 Aug;270(2):768-78.
4
Allosteric modulation of Torpedo nicotinic acetylcholine receptor ion channel activity by noncompetitive agonists.
J Recept Signal Transduct Res. 1997 Jan-May;17(1-3):11-28. doi: 10.3109/10799899709036592.
5
The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter release.加兰他敏对烟碱型乙酰胆碱受体的变构增强作用在神经元中转化为细胞反应:钙离子信号和神经递质释放。
Mol Pharmacol. 2003 Nov;64(5):1217-26. doi: 10.1124/mol.64.5.1217.
6
Diversity of nicotinic acetylcholine receptors in rat brain. V. alpha-Bungarotoxin-sensitive nicotinic receptors in olfactory bulb neurons and presynaptic modulation of glutamate release.大鼠脑中烟碱型乙酰胆碱受体的多样性。V. 嗅球神经元中对α-银环蛇毒素敏感的烟碱型受体以及谷氨酸释放的突触前调节。
J Pharmacol Exp Ther. 1996 Sep;278(3):1460-71.
7
Noncompetitive agonism at nicotinic acetylcholine receptors; functional significance for CNS signal transduction.
J Recept Signal Transduct Res. 1995 Jan-Mar;15(1-4):333-53. doi: 10.3109/10799899509045225.
8
Iptakalim inhibits nicotinic acetylcholine receptor-mediated currents in dopamine neurons acutely dissociated from rat substantia nigra pars compacta.埃他卡林抑制从大鼠黑质致密部急性分离的多巴胺能神经元中烟碱型乙酰胆碱受体介导的电流。
Neurosci Lett. 2006 Jul 31;403(1-2):57-62. doi: 10.1016/j.neulet.2006.04.060. Epub 2006 May 26.
9
Dual action of n-alcohols on neuronal nicotinic acetylcholine receptors.正构醇对神经元烟碱型乙酰胆碱受体的双重作用。
Mol Pharmacol. 2001 Oct;60(4):700-11.
10
Paraoxon: cholinesterase-independent stimulation of transmitter release and selective block of ligand-gated ion channels in cultured hippocampal neurons.对氧磷:培养海马神经元中递质释放的胆碱酯酶非依赖性刺激及配体门控离子通道的选择性阻断
J Pharmacol Exp Ther. 1996 Sep;278(3):1175-87.

引用本文的文献

1
Targeting the cholinergic anti-inflammatory pathway for type 2 diabetes prevention: A retrospective cohort study.靶向胆碱能抗炎途径预防2型糖尿病:一项回顾性队列研究。
Diabetes Obes Metab. 2025 Feb;27(2):675-682. doi: 10.1111/dom.16060. Epub 2024 Nov 11.
2
A developmental gradient reveals biosynthetic pathways to eukaryotic toxins in monocot geophytes.发育梯度揭示了单子叶植物地生植物中真核毒素的生物合成途径。
Cell. 2024 Oct 3;187(20):5620-5637.e10. doi: 10.1016/j.cell.2024.08.027. Epub 2024 Sep 13.
3
Auditory mismatch responses are differentially sensitive to changes in muscarinic acetylcholine versus dopamine receptor function.
听觉失匹配响应对毒蕈碱型乙酰胆碱受体与多巴胺受体功能变化的敏感性存在差异。
Elife. 2022 May 3;11:e74835. doi: 10.7554/eLife.74835.
4
Natural Polysaccharides as Preventive and Therapeutic Horizon for Neurodegenerative Diseases.天然多糖作为神经退行性疾病的预防和治疗前景
Pharmaceutics. 2021 Dec 21;14(1):1. doi: 10.3390/pharmaceutics14010001.
5
Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Are Irreversible Inhibitors the Future?提高乙酰胆碱酯酶抑制剂在阿尔茨海默病中的神经退行性保护作用:不可逆抑制剂是未来的趋势吗?
Int J Mol Sci. 2020 May 13;21(10):3438. doi: 10.3390/ijms21103438.
6
Regulation of aggressive behaviors by nicotinic acetylcholine receptors: Animal models, human genetics, and clinical studies.烟碱型乙酰胆碱受体对攻击行为的调控:动物模型、人类遗传学和临床研究。
Neuropharmacology. 2020 May 1;167:107929. doi: 10.1016/j.neuropharm.2019.107929. Epub 2019 Dec 26.
7
Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy.天然存在的乙酰胆碱酯酶抑制剂及其在阿尔茨海默病治疗中的潜在用途。
Front Pharmacol. 2018 Oct 18;9:1192. doi: 10.3389/fphar.2018.01192. eCollection 2018.
8
Galantamine is not a positive allosteric modulator of human α4β2 or α7 nicotinic acetylcholine receptors.加兰他敏不是人源 α4β2 或 α7 型烟碱型乙酰胆碱受体的正别构调节剂。
Br J Pharmacol. 2018 Jul;175(14):2911-2925. doi: 10.1111/bph.14329. Epub 2018 Jun 7.
9
Post-Injury Administration of Galantamine Reduces Traumatic Brain Injury Pathology and Improves Outcome.伤后给予加兰他敏可减轻创伤性脑损伤病理改变并改善预后。
J Neurotrauma. 2018 Jan 15;35(2):362-374. doi: 10.1089/neu.2017.5102. Epub 2017 Dec 18.
10
Neuroprotective Effects of Galantamine on Nerve Agent-Induced Neuroglial and Biochemical Changes.加兰他敏对神经毒剂诱导的神经胶质和生化变化的神经保护作用。
Neurotox Res. 2018 May;33(4):738-748. doi: 10.1007/s12640-017-9815-9. Epub 2017 Sep 19.